William J Newell insider trades

Open-market stock purchases and sales by William J Newell, CEO at Sutro Biopharma, Inc, from SEC Form 4 filings since Sep 26, 2018.

Track record: 100% of 2 scored buys are up 5% or more since purchase, averaging +103%.

Recent trades

No open-market trades in the last 12 months.

Companies traded

  • STRO Sutro Biopharma, Inc: 2 buys, last Mar 5, 2025
  • PCVX Vaxcyte, Inc: other filings, last Dec 9, 2020

Get free alerts when William J Newell files a new trade →